Similar articles

• Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey.

  Puddu PE, Jouve R, Saadjian A, Torresani J. Puddu PE, et al. J Pharmacol. 1986 Jul-Sep;17(3):223-43. J Pharmacol. 1986. PMID: 3795968
• Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction.

  Dhurandhar RW, Pickron J, Goldman AM. Dhurandhar RW, et al. Heart Lung. 1980 Mar-Apr;9(2):265-70. Heart Lung. 1980. PMID: 6898604
• Usefulness of prophylactic bretylium in preventing ventricular fibrillation complication acute myocardial infarction.

  [No authors listed] [No authors listed] Heart Lung. 1980 Sep-Oct;9(5):910-1. Heart Lung. 1980. PMID: 6904422 No abstract available.
• Drug therapy: bretylium.

  Koch-Weser J. Koch-Weser J. N Engl J Med. 1979 Mar 1;300(9):473-7. doi: 10.1056/NEJM197903013000905. N Engl J Med. 1979. PMID: 366419 Review. No abstract available.
• Prophylaxis and therapy of ventricular fibrillation: bretylium reviewed and lidocaine refuted.

  Bacaner M. Bacaner M. Int J Cardiol. 1983 Sep;4(2):133-52. doi: 10.1016/0167-5273(83)90128-6. Int J Cardiol. 1983. PMID: 6354941 Review. No abstract available.